Leverages Innovative Technologies, Personalized Approach for Medication-free Treatment Options
Medford, N.Y., – September 9, 2020 — Long Island NeuroCare Therapy, the flagship neuroCare Centers of America clinic network in New York, today announced it is celebrating its 10-year anniversary of providing Transcranial Magnetic Stimulation (TMS) Therapy for depression, marking a great achievement and a major milestone. The organization focuses on leveraging innovative technologies and its personalized care approach to provide medication-free treatment options.
The FDA cleared TMS Therapy for clinical use in 2008. This revolutionary technology has quickly become the new standard of care for treatment-resistant depression and Major Depressive Disorder (MDD) as a proven safe and effective non-drug treatment option.
TMS Therapy technology targets neuronal-networks that cause depression in a way no other treatment method can. It utilizes MRI-strength magnetic pulse technology to non-invasively excite neuronal networks in the brain involved in mood regulation. TMS Therapy improves regional blood flow and metabolic activity, as well as facilitates the production of neurotransmitters important in mood regulation.
Nationally recognized, board-certified psychiatrist, Dr. Richard Jay Pitch blazed the trail for TMS Therapy on Long Island as one of the first physicians to offer this advanced technology in 2010.
“These past decade has been a rewarding experience for me beyond the walls of the clinic, to see the transformative impact on my patients and their loved ones,” said Dr. Richard J. Pitch, Medical Director at Long Island Neurocare Therapy. “The advent of TMS technology is truly a game-changer in depression care, and I’m very pleased to be able to be part of this patient care revolution.”
With 25 years of experience in the treatment of clinical depression and his pioneering efforts in TMS Therapy, Dr. Pitch was the top choice for neuroCare Centers of America’s U.S. expansion as the organization researched the Long Island market. neuroCare tapped Dr. Pitch as the medical director to lead its new venture, Long Island NeuroCare Therapy, with its initial location in Medford, N.Y.
In July 2017, Dr. Pitch and Long Island NeuroCare Therapy opened a second location in Melville to improve patient access to TMS Therapy, expand clinical expertise and resources while combining leading technologies and treatment protocols to improve patient outcomes for Suffolk and Eastern Nassau County residents. Through this partnership, Long Island NeuroCare Therapy represents Long Island’s most experienced and largest provider of TMS Therapy. The organization also maintains some of the industry’s best clinical outcomes, collectively having treated 450+ patients and administering more than 21,000 TMS treatment sessions.
“We are honored to partner with a physician of Dr. Pitch’s caliber,” said Stanford Miller, Managing Director, neuroCare Group America, Inc. “His patient-centric approach, early adoption TMS technology and track record align with our mission of improving the lives of patients suffering from mental health conditions.”
Long Island NeuroCare Therapy uses NeuroStar® TMS technology and is one of 108 practices to participate in the company-sponsored TMS Clinical Outcomes Registry. The Outcomes Registry collected TMS Therapy patient outcomes data spanning September 2016 – May 2020, which included 5,230 patients and demonstrated that TMS Therapy could transform patients’ lives suffering from depression. The physician- rated data showed that 73 percent of patients respond well, and 52 percent of patients achieve full remission when completing a full course of TMS Therapy.
The NeuroStar® Outcomes Registry is now the largest dataset in the treatment of major depression field, surpassing the U.S. government’s National Institute of Mental Health STAR*D (Sequenced Treatment Alternatives to Relieve Depression) study that tracked clinical results for 3,671 patients with major depression.
Dr. Pitch serves as medical director at Long Island NeuroCare Therapy clinics, which are staffed by registered nurses, certified TMS Therapy technicians, and QEEG, neurofeedback, and sleep-hygiene specialists. All staff is expertly trained to deliver neuroCare’s innovative therapies to patients looking for non-medication solutions to mental health conditions.
Long Island NeuroCare Therapy is accepting new patients at both its Medford and Melville, N.Y. clinic locations.
neuroCare Centers of America is part of an international network of clinics focused on delivering personalized care to positively impact brain function. This network offers access to industry-leading research and world-class training, providing unique resources in the neuromodulation clinical service arena. neuroCare counts four U.S.-based clinics, two in New York and two in Tennessee, plus the organization’s global network of 15 locations, including clinics in Australia, Germany, Italy and the Netherlands.
About Long Island NeuroCare Therapy
Long Island NeuroCare Therapy specializes in Transcranial Magnetic Stimulation (TMS) Therapy and Neurofeedback. We provide safe and well-researched therapies for depression, ADHD, and sleep problems—all without the need for medication.
Long Island NeuroCare Therapy is the flagship neuroCare Centers of America clinic network in New York.
TMS Therapy and Neurofeedback are innovative technologies that are 100% drug-free, safe, effective, and non-invasive. These advanced technologies utilize neuromodulation techniques to leverage the brain’s natural ability to build new or improve the function of existing neural networks that control mood and behavior. TMS Therapy and Neurofeedback are clinically-proven therapy programs that provide long-term sustainable results.
Long Island NeuroCare Therapy offers its patients individually tailored treatment plans that help patients regain a healthier brain and a better quality of life. With our technologies, remission from the symptoms of depression, ADHD and sleep disorders is possible.
For more information, visit longislandneurocaretherapy.com or call (631-714-4100).
About neuroCare Centers of America
neuroCare Centers of America is part of an international network of centers of excellence dedicated to helping patients suffering from neuropsychiatric illnesses that have not been helped by traditional medication management. The network includes locations in Australia, Germany, Italy and the Netherlands.
For more information, visit neurocarecentersofamerica.com